Literature DB >> 11463766

Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension.

S Sasaki1, Y Higashi, K Nakagawa, H Matsuura, G Kajiyama, T Oshima.   

Abstract

Previous animal studies have shown that angiotensin (Ang)-(1-7) is a biologically active component of the renin-angiotensin system, acting as a vasoactive agent, and may play a role in the blood pressure regulation. There is little information, however, on the effect of Ang-(1-7) on human circulation or the mechanism of its action. To investigate the effect of Ang-(1-7) on forearm circulation and to determine whether this effect is altered in patients with essential hypertension, we measured change in forearm blood flow using venous occlusion plethysmography in response to intra-arterial infusion of Ang-(1-7) (10(-10), 10(-9), and 10(-8) mol/min; for 5 minutes) in normotensive control subjects (n=8) and patients with essential hypertension (n=8). Infusion of Ang-(1-7) significantly increased the forearm blood flow response in a dose-dependent manner in both normotensive control subjects (28.7+/-9.7%, at 10(-8) mol/min; P<0.05) and hypertensive patients (31.8+/-15.2%, at 10(-8) mol/min; P<0.05). The vasodilatory effect of Ang-(1-7) was similar in the two groups. Intra-arterial infusion of N(G)-monomethyl-L-arginine, a nitric oxide synthesis inhibitor, did not alter the forearm blood flow response to Ang-(1-7) in either group. These findings suggest that Ang-(1-7) causes vasodilation in forearm circulation of normotensive subjects and patients with essential hypertension through a pathway that is independent of nitric oxide synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463766     DOI: 10.1161/01.hyp.38.1.90

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

1.  Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Authors:  Marlies Antlanger; Oliver Domenig; Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Marko Poglitsch; Marcus D Säemann
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Apr-Jun       Impact factor: 1.636

2.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

3.  Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

4.  Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.

Authors:  Daniela Medina; Amy C Arnold
Journal:  Am J Hypertens       Date:  2019-11-15       Impact factor: 2.689

Review 5.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 6.  Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.

Authors:  Rodrigo Araujo Fraga-Silva; Anderson Jose Ferreira; Robson Augusto Souza Dos Santos
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

7.  Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.

Authors:  Shinji Hisatake; Shunsuke Kiuchi; Takayuki Kabuki; Takashi Oka; Shintaro Dobashi; Takanori Ikeda
Journal:  Heart Vessels       Date:  2016-07-15       Impact factor: 2.037

8.  Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase.

Authors:  Matthew J Durand; Natalya S Zinkevich; Michael Riedel; David D Gutterman; Victoria L Nasci; Valerie K Salato; John B Hijjawi; Charles F Reuben; Paula E North; Andreas M Beyer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-14       Impact factor: 8.311

9.  Angiotensin-(1-7) oral formulation improves physical performance in mountain bike athletes: a double-blinded crossover study.

Authors:  Samara Silva de Moura; Adália Táci Pereira Mendes; Francisco de Assis Dias Martins-Júnior; Nádia Lúcia Totou; Daniel Barbosa Coelho; Emerson Cruz de Oliveira; Daisy Motta-Santos; Robson Augusto Souza Dos Santos; Lenice Kappes Becker
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-05-06

Review 10.  Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.

Authors:  T D Giles; G E Sander
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.